NEW YORK, March 3 - Genomic Solutions, a wholly owned subsidiary of Harvard Bioscience, said today that it plans to acquire genomic tool company GeneMachines for around $8.3 million in cash.
The acquisition is expected to close in mid March, subject to the approval of GeneMachines' shareholders. According to Harvard Bioscience, enough GeneMachines shareholders necessary to approve the transaction have already entered agreed to vote in favor of the acquisition.
GeneMachines develops and distributes high-throughput instrumentation for DNA and protein microarray production, nucleic acid sample preparation, and DNA synthesis.
Click here for further information.